Become part of the Myeloma Crowd – a new and important multiple myeloma patient community.
May 09, 2019
This is not quite a multiple myeloma article, but still good to know … I am quite certain that over the past week many of us have seen the blizzard of press mentions of the early results of the investigational anti-BCMA CAR-T product bb2121 (Bluebird-Celgene) in MM patients published in the New England Journal of […]
May 08, 2019
Last week the New England Journal of Medicine published results from the Phase I Celgene bb2121 CAR T clinical trial. In the Phase I study, 33 patients with relapsed or refractory myeloma were giving bb2121 as a single infusion of the CAR T product at different doses in the dose escalation phase (50×106, 150×106, 450×106, […]
Mar 28, 2019
How can myeloma patients sleep better when living with cancer? A new phase III study is comparing three groups: yoga, survivorship health education and cognitive behavior therapy to see which is most effective in reducing insomnia in cancer survivors. Insomnia is excessive daytime napping, difficulty falling asleep, difficulty staying asleep, or waking up earlier than […]
Thanks to our site sponsors: